Serotonin transporter polymorphisms (5-HTTLPR) in emotion processing. Implications from current neurobiology.

Progress in Neurobiology

Volumn 117, Issue , 2014, Pages 41-53

  Jonassen, R ^a   Landro N I ^a  

^a Clinical Neuroscience Research Group Department of Psychology   (Norway)

Author keywords

Candidate gene approach; Emotion processing; Serotonin

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER;

EMOTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); NERVE CELL PLASTICITY; NEUROBIOLOGY; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW (TOPIC); ANIMAL; BRAIN; COGNITION; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; COGNITION; EMOTIONS; HUMANS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84900509461     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2014.02.003     Document Type: Review

References (117)

1. Autry A.E., Monteggia L.M. Epigenetics in suicide and depression. Biol. Psychiatry 2009, 66:812-813.
2. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005, 8:1458-1463.
3. Beevers C.G., McGeary J.E. Therapygenetics: moving towards personalized psychotherapy treatment. Trends Cogn. Sci. 2012, 16.
4. Beevers C.G., Wells T.T., Ellis A.J., McGeary J.E. Association of the serotonin transporter gene promoter region (5-HTTLPR) polymorphism with biased attention for emotional stimuli. J. Abnorm. Psychol. 2009, 118:670-681.
5. Beevers C.G., Ellis A.J., Wells T.T., McGeary J.E. Serotonin transporter gene promoter region polymorphism and selective processing of emotional images. Biol. Psychol. 2010, 83:260-265.
6. Beevers C.G., Pacheco J., Clasen P., McGeary J.E., Schnyer D. Prefrontal morphology, 5-HTTLPR polymorphism and biased attention for emotional stimuli. Genes Brain Behav. 2010, 9:224-233.
7. Beevers C.G., Marti C.N., Lee H.J., Stote D.L., Ferrell R.E., Hariri A.R., Telch M.J. Associations between serotonin transporter gene promoter region (5-HTTLPR) polymorphism and gaze bias for emotional information. J. Abnorm. Psychol. 2011, 120:187-197.
8. Bertolino A., Arciero G., Rubino V., Latorre V., De Candia M., Mazzola V., Blasi G., Caforio G., Hariri A., Kolachana B., Nardini M., Weinberger D.R., Scarabino T. Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol. Psychiatry 2005, 57:1517-1525.
9. Borg J., Henningsson S., Saijo T., Inoue M., Bah J., Westberg L., Lundberg J., Jovanovic H., Andree B., Nordstrom A.-L., Halldin C., Eriksson E., Farde L. Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans. Int. J. Neuropsychopharmacol. 2009, 12:783-792.
10. Brockmann H., Zobel A., Schuhmacher A., Daamen M., Joe A., Biermann K., Schwab S.G., Biersack H.J., Maier W., Boecker H. Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression. J. Psychiatr. Res. 2011, 45:442-451.
11. Browning M., Reid C., Cowen P.J., Goodwin G.M., Harmer C.J. A single dose of citalopram increases fear recognition in healthy subjects. J. Psychopharmacol. (Oxf.) 2007, 21(7):684-690.
12. Brummett B.H., Boyle S.H., Siegler I.C., Kuhn C.M., Ashley-Koch A., Jonassaint C.R., Zuchner S., Collins A., Williams R.B. Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav. Genet. 2008, 38:34-43.
13. Buznikov G.A., Lambert H.W., Lauder J.M. Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis. Cell Tissue Res. 2001, 305:177-186.
14. Canli T., Lesch K.P. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat. Neurosci. 2007, 10:1103-1109.
15. Canli T., Omura K., Haas B.W., Fallgatter A., Constable R.T., Lesch K.P. Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12224-12229.
16. Canli T., Qiu M., Omura K., Congdon E., Haas B.W., Amin Z., Herrmann M.J., Constable R.T., Lesch K.P. Neural correlates of epigenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16033-16038.
17. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
18. Clark L., Roiser J.P., Cools R., Rubinsztein D.C., Sahakian B.J., Robbins T.W. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl.) 2005, 182:570-578.
19. Dannlowski U., Ohrmann P., Bauer J., Deckert J., Hohoff C., Kugel H., Arolt V., Heindel W., Kersting A., Baune B.T., Suslow T. 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology 2008, 33:418-424.
20. Dannlowski U., Konrad C., Kugel H., Zwitserlood P., Domschke K., Schoning S., Ohrmann P., Bauer J., Pyka M., Hohoff C., Zhang W., Baune B.T., Heindel W., Arolt V., Suslow T. Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype. Neuroimage 2010, 53:893-898.
21. Domschke K., Braun M., Ohrmann P., Suslow T., Kugel H., Bauer J., Hohoff C., Kersting A., Engelien A., Arolt V., Heindel W., Deckert J. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3T fMRI in panic disorder. Int. J. Neuropsychopharmacol. 2006, 9:349-355.
22. Eley T.C., Sugden K., Corsico A., Gregory A.M., Sham P., McGuffin P., Plomin R., Craig I.W. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol. Psychiatry 2004, 9:908-915.
23. Eley T.C., Hudson J.L., Creswell C., Tropeano M., Lester K.J., Cooper P., Farmer A., Lewis C.M., Lyneham H.J., Rapee R.M., Uher R., Zavos H.M.S., Collier D.A. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol. Psychiatry 2012, 17:236-237.
24. Fink G., Sumner B.E., McQueen J.K., Wilson H., Rosie R. Sex steroid control of mood, mental state and memory. Clin. Exp. Pharmacol. Physiol. 1998, 25:764-775.
25. Fox E., Ridgewell A., Ashwin C. Looking on the bright side: biased attention and the human serotonin transporter gene. Proc. Biol. Sci. 2009, 276:1747-1751.
26. Fox E., Zougkou K., Ridgewell A., Garner K. The serotonin transporter gene alters sensitivity to attention bias modification: evidence for a plasticity gene. Biol. Psychiatry 2011, 70:1049-1054.
27. Frodl T., Zill P., Baghai T., Schule C., Rupprecht R., Zetzsche T., Bondy B., Reiser M., Moller H.J., Meisenzahl E.M. Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. Am. J. Med. Genet. 2008, 147B:1003-1007.
28. Furman D.J., Hamilton J.P., Joormann J., Gotlib I.H. Altered timing of amygdala activation during sad mood elaboration as a function of 5-HTTLPR. Soc. Cogn. Affect. Neurosci. 2011, 6:270-276.
29. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4:1002-1012.
30. Gibb B.E., Benas J.S., Grassia M., McGeary J. Children's attentional biases and 5-HTTLPR genotype: potential mechanisms linking mother and child depression. J. Clin. Child Adol. Psychol. 2009, 38:415-426.
31. Glennon R.A., Malgorzata D., Westkaemper R.B. Serotonin receptor subtypes and ligands. Psychopharmacology: The Fourth Generation of Progress 1998, Raven Press, New York. F.E. Bloom, D.J. Kopfer (Eds.).
32. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 1999, 88:83-87.
33. Grillon C., Levenson J., Pine D.S. A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 2007, 32:225-231.
34. Grillon C., Chavis C., Covington M.F., Pine D.S. Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study. Neuropsychopharmacology 2009, 34(4):964-971.
35. Hamann S. Blue genes: wiring the brain for depression. Nat. Neurosci. 2005, 8:701-703.
36. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
37. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 2005, 62:146-152.
38. Harmer C.J., Bhagwagar Z., Perrett D.I., Vollm B.A., Cowen P.J., Goodwin G.M. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 2003, 28(1):148-152.
39. Harmer C.J., Shelley N.C., Cowen P.J., Goodwin G.M. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am. J. Psychiatry 2004, 161(7):1256-1263.
40. He Q., Xue G., Chen C., Lu Z., Dong Q., Lei X., Ding N., Li J., Li H., Moyzis R.K., Bechara A. Serotonin transporter gene-linked polymorphic region (5-HTTLPR) influences decision making under ambiguity and risk in a large Chinese sample. Neuropharmacology 2010, 59:518-526.
41. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996, 66:2621-2624.
42. Heinz A., Jones D.W., Mazzanti C., Goldman D., Ragan P., Hommer D., Linnoila M., Weinberger D.R. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol. Psychiatry 2000, 47:643-649.
43. Heinz A., Braus D.F., Smolka M.N., Wrase J., Puls I., Hermann D., Klein S., Grusser S.M., Flor H., Schumann G., Mann K., Buchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 2005, 8:20-21.
44. Hensler J.G. Serotonin. Basic Neurochemistry. Principles of Molecular, Cellular, and Medical Neurobiology 2012, Elsevier Inc., Oxford, UK. S.T. Brady, G.J. Siegel, R. Wayne Albers, D.L. Price (Eds.).
45. Herman K.N., Winslow J.T., Suomi S.J. Primate models in serotonin transporter research. Experimental Models in Serotonin Transporter Research 2010, 288-307. Cambridge University Press, New York. A.V. Kalueff, J.L. Laporte (Eds.).
46. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci. Biobehav. Rev. 2008, 32:1293-1314.
47. Holmes A.J., Bogdan R., Pizzagalli D.A. Serotonin transporter genotype and action monitoring dysfunction: a possible substrate underlying increased vulnerability to depression. Neuropsychopharmacology 2010, 35:1186-1197.
48. Homberg J.R., Lesch K.P. Looking on the bright side of serotonin transporter gene variation. Biol. Psychiatry 2010, 513-519.
49. Homberg J.R., van den Bos R., den Heijer E., Suer R., Cuppen E. Serotonin transporter dosage modulates long-term decision-making in rat and human. Neuropharmacology 2008, 55:80-84.
50. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 2006, 78:815-826.
51. Jabbi M., Korf J., Kema I.P., Hartman C., van der Pompe G., Minderaa R.B., Ormel J., den Boer J.A. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol Psychiatry 2007, 12:483-490.
52. Jonassen R., Endestad T., Neumeister A., Foss Haug K.B., Berg J.P., Landro N.I. The effects of the serotonin transporter polymorphism and age on frontal white matter integrity in healthy adult women. Front. Hum. Neurosci. 2012, 6.
53. Jonassen R., Endestad T., Neumeister A., Foss Haug K.B., Berg J.P., Landro N.I. Serotonin transporter polymorphism modulates N-back task performance, fMRI BOLD signal intensity in healthy women. PLoS One 2012, 7:e30564. (Electronic Resource).
54. Jonassen R., Foss Haug K.B., Endestad T., Bentsen H., Grimholt R.M., Landro N.I. Associations between serotonin transporter polymorphisms and cognitive processing applying the Emo 1-back task. Cogn. Emot. 2012, 27:465-473.
55. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch. Gen. Psychiatry 2005, 62:529-535.
56. Kojic L., Dyck R.H., Gu Q., Douglas R.M., Matsubara J., Cynader M.S. Columnar distribution of serotonin-dependent plasticity within kitten striate cortex. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1841-1844.
57. Kraft J.B., Slager S.L., McGrath P.J., Hamilton S.P. Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol. Psychiatry 2005, 58:374-381.
58. Kwang T., Wells T.T., McGeary J.E., Swann W.B., Beevers C.G. Association of the serotonin transporter promoter region polymorphism with biased attention for negative word stimuli. Depress. Anxiety 2010, 27:746-751.
59. Lage G.M., Malloy-Diniz L.F., Matos L.O., Bastos M.A.R., Abrantes S.S.C., Correa H. Impulsivity and the 5-HTTLPR polymorphism in a non-clinical sample. PLoS One 2011, 6.
60. Lesch K.P. The role of serotonin transporter in modeling psychiatric disorders: focus on depression, emotion regulation and the social brain. Experimental Models in Serotonin Transporter Research 2010, 308-352. Cambridge University Press, New York. A.V. Kalueff, J.L. Laporte (Eds.).
61. Lesch K.P., Gutknecht L. Pharmacogenetics of the serotonin transporter. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:1062-1073.
62. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
63. Lieske V., Bennett-Clarke C.A., Rhoades R.W. Effects of serotonin on neurite outgrowth from thalamic neurons in vitro. Neuroscience 1999, 90:967-974.
64. Lim J.E., Papp A., Pinsonneault J., Sadee W., Saffen D. Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol. Psychiatry 2006, 11:649-662.
65. Little K.Y., McLaughlin D.P., Zhang L., Livermore C.S., Dalack G.W., McFinton P.R., DelProposto Z.S., Hill E., Cassin B.J., Watson S.J., Cook E.H. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am. J. Psychiatry 1998, 155:207-213.
66. Little J., Higgins J.P., Ioannidis J.P., Moher D., Gagnon F., von Elm E., Studies S.T.t.R.o.G.A. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009, 6(2):151-163.
67. Lonsdorf T.B., Golkar A., Lindstom K.M., Fransson P., Schalling M., Ohman A., Ingvar M. 5-HTTLPR and COMTval158met genotype gate amygdala reactivity and habituation. Biol. Psychol. 2011, 87:106-112.
68. Luellen A.B., Gilman T.L., Andrews A.M. Presynaptic adaptive responses to constitutive versus adult pharmacologic inhibition of serotonin uptake. Experimental Models in Serotonin Transporter Research 2010, Cambridge University Press, New York. A.V. Kalueff, J.L. Laporte (Eds.).
69. MacLeod C., Rutherford E., Campbell L., Ebsworthy G., Holker L. Selective attention and emotional vulnerability: assessing the causal basis of their association through the experimental manipulation of attentional bias. J. Abnorm. Psychol. 2002, 111:107-123.
70. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry 2000, 57:729-738.
71. Martin J., Cleak J., Willis-Owen S.A., Flint J., Shifman S. Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance. Mol. Psychiatry 2007, 12:421-422.
72. McGuffin P., Alsabban S., Uher R. The truth about genetic variation in the serotonin transporter gene and response to stress and medication. Br. J. Psychiatry 2011, 198:424-427.
73. Meyer-Lindenberg A. The future of fmri and genetics research. First Posting Oct 28, 2011. Neuroimage 2011, (October).
74. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 2006, 7:818-827.
75. Miskowiak K., Papadatou-Pastou M., Cowen P.J., Goodwin G.M., Norbury R., Harmer C.J. Single dose antidepressant administration modulates the neural processing of self-referent personality trait words. Neuroimage 2007, 37:904-911.
76. Mortensen O.V., Thomassen M., Larsen M.B., Whittemore S.R., Wiborg O. Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells. Brain Res. Mol. Brain Res. 1999, 68:141-148.
77. Munafo M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol. Psychiatry 2008, 63:852-857.
78. Murphy S.E., Norbury R., O'Sullivan U., Cowen P.J., Harmer C.J. Effect of a single dose of citalopram on amygdala response to emotional faces. Br. J. Psychiatry 2009, 194.
79. Murphy S.E., Norbury R., Godlewska B.R., Cowen P.J., Mannie Z.M., Harmer C.J., Munafo M.R. The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis. Mol. Psychiatry 2012.
80. Must A., Juhasz A., Rimanoczy A., Szabo Z., Keri S., Janka Z. Major depressive disorder, serotonin transporter, and personality traits: why patients use suboptimal decision-making strategies?. J. Affect. Disord. 2007, 103:273-276.
81. Nakamura M., Ueno S., Sano A., Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 2000, 5:32-38.
82. Norbury R., Mackay C.E., Cowen P.J., Goodwin G.M., Harmer C.J. The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study. Mol. Psychiatry 2008, 13:1011-1020.
83. O'Hara R., Schroder C.M., Mahadevan R., Schatzberg A.F., Lindley S., Fox S., Weiner M., Kraemer H.C., Noda A., Lin X., Gray H.L., Hallmayer J.F. Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol. Psychiatry 2007, 12:544-555.
84. O'Nions E.J., Dolan R.J., Roiser J.P. Serotonin transporter genotype modulates subgenual response to fearful faces using an incidental task. J. Cogn. Neurosci. 2011, 23:3681-3693.
85. Osinsky R., Reuter M., Kupper Y., Schmitz A., Kozyra E., Alexander N., Hennig J. Variation in the serotonin transporter gene modulates selective attention to threat. Emotion 2008, 8:584-588.
86. Paaver M., Nordquist N., Parik J., Harro M., Oreland L., Harro J. Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing. Psychopharmacology (Berl.) 2007, 194:545-554.
87. Pacheco J., Beevers C.G., Benavides C., McGeary J., Stice E., Schnyer D.M. Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism. J. Neurosci. 2009, 29:6229-6233.
88. Parsey R.V., Hastings R.S., Oquendo M.A., Hu X., Goldman D., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., Mann J.J. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am. J. Psychiatry 2006, 163:48-51.
89. Patkar A.A., Berrettini W.H., Mannelli P., Gopalakrishnan R., Hoehe M.R., Bilal L., Weinstein S., Vergare M.J. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers. Psychiatr. Genet. 2004, 14:25-32.
90. Perez-Edgar K., Bar-Haim Y., McDermott J.M., Gorodetsky E., Hodgkinson C.A., Goldman D., Ernst M., Pine D.S., Fox N.A. Variations in the serotonin-transporter gene are associated with attention bias patterns to positive and negative emotion faces. Biol. Psychol. 2010, 83:269-271.
91. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8:828-834.
92. Phillips M.L. Understanding the neurobiology of emotion perception: implications for psychiatry. Br. J. Psychiatry 2003, 182:190-192.
93. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol. Psychiatry 2003, 54:504-514.
94. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol. Psychiatry 2003, 54:515-528.
95. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35:192-216.
96. Rao H., Gillihan S.J., Wang J., Korczykowski M., Sankoorikal G.M., Kaercher K.A., Brodkin E.S., Detre J.A., Farah M.J. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biol. Psychiatry 2007, 62:600-606.
97. Roffman J.L., Marci C.D., Glick D.M., Dougherty D.D., Rauch S.L. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol. Med. 2005, 35:1385-1398.
98. Roiser J.P., Blackwell A.D., Cools R., Clark L., Rubinsztein D.C., Robbins T.W., Sahakian B.J. Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology 2006, 31:2264-2272.
99. Roiser J.P., Rogers R.D., Cook L.J., Sahakian B.J. The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology (Berl.) 2006, 188:213-227.
100. Roiser J.P., Muller U., Clark L., Sahakian B.J. The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention. Int. J. Neuropsychopharmacol. 2007, 10:449-461.
101. Scharinger C., Rabl U., Pezawas L., Kasper S. The genetic blueprint of major depressive disorder: contributions of imaging genetics studies. World J. Biol. Psychiatry 2011, 474-488.
102. Selvaraj S., Godlewska B.R., Norbury R., Bose S., Turkheimer F., Stokes P., Rhodes R., Howes O., Cowen P.J. Decreased regional gray matter volume in S' allele carriers of the 5-HTTLPR triallelic polymorphism. Mol. Psychiatry 2011, 16:472-473.
103. Serretti A., Gibiino S., Olgiati P. Pharmacogenetics of antidepressants and mood stabilizers. Handb. Clin. Neurol. 2012, 106:715-744.
104. Sjoberg R.L., Nilsson K.W., Nordquist N., Ohrvik J., Leppert J., Lindstrom L., Oreland L. Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int. J. Neuropsychopharmacol. 2006, 9:443-449.
105. Stein A., Murphy S., Arteche A., Lehtonen A., Harvey A., Craske M.G., Harmer C. Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases. J. Psychopharmacol. 2012, 26:670-676.
106. Stoltenberg S.F., Vandever J.M. Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk. Neuropharmacology 2010, 58:423-428.
107. Strobel A., Dreisbach G., Muller J., Goschke T., Brocke B., Lesch K.P. Genetic variation of serotonin function and cognitive control. J. Cogn. Neurosci. 2007, 19:1923-1931.
108. Thase M.E. Neurobiological aspects of depression. Handbook of Depression 2009, 187-217. The Guilford Press, New York. I.H. Gotlib, C.L. Hammen (Eds.).
109. Uher R., McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol. Psychiatry 2010, 15:18-22.
110. Viviani R., Sim E.J., Lo H., Beschoner P., Osterfeld N., Maier C., Seeringer A., Godoy A.L., Rosa A., Comas D., Kirchheiner J. Baseline brain perfusion and the serotonin transporter promoter polymorphism. Biol. Psychiatry 2010, 67:317-322.
111. Walderhaug E., Herman A.I., Magnusson A., Morgan M.J., Landro N.I. The short (S) allele of the serotonin transporter polymorphism and acute tryptophan depletion both increase impulsivity in men. Neurosci. Lett. 2010, 473:208-211.
112. Wang F., Kalmar J.H., He Y., Jackowski M., Chepenik L.G., Edmiston E.E., Tie K., Gong G., Shah M.P., Jones M., Uderman J., Constable R.T., Blumberg H.P. Functional and structural connectivity between the perigenual anterior cingulate and amygdala in bipolar disorder. Biol. Psychiatry 2009, 66:516-521.
113. Wells T.T., Clerkin E.M., Ellis A.J., Beevers C.G. Effect of antidepressant medication use on emotional information processing in major depression. Am. J. Psychiatry 2014, 171:195-200.
114. Wendland J.R., Martin B.J., Kruse M.R., Lesch K.P., Murphy D.L. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol. Psychiatry 2006, 11:224-226.
115. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull. 2001, 56:479-485.
116. Zalsman G., Anderson G.M., Peskin M., Frisch A., King R.A., Vekslerchik M., Sommerfeld E., Michaelovsky E., Sher L., Weizman A., Apter A. Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients. J. Neural Transm. 2005, 112:309-315.
117. Zhao J., Goldberg J., Bremner J.D., Vaccarino V. Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study. Psychosom. Med. 2013, 75(6):523-529.